Orthobiologics Global Market Report 2024

Description

Orthobiologics refer to therapies derived from natural substances utilized in treating various musculoskeletal conditions. These therapies aim to enhance the body's capacity to repair and regenerate bones, cartilage, tendons, and ligaments in orthopedic treatments, ultimately improving recovery times and outcomes in procedures such as spinal fusion, fracture repair, and joint reconstruction.

The main products of orthobiologics include viscosupplements, bone growth factors, demineralized bone matrix, synthetic bone substitutes, cellular allografts, and others. Viscosupplements are gel-like substances injected into joints to provide lubrication and cushioning, thereby reducing pain and enhancing mobility in individuals with osteoarthritis. These products find applications across various fields, including spinal fusion, maxillofacial and dental surgeries, soft tissue repair, reconstructive and fracture surgery, and others. They are utilized by various end users such as hospitals, orthopedic clinics, ambulatory surgery centers, and others.

The orthobiologics market research report is one of a series of new reports from The Business Research Company that provides orthobiologics market statistics, including the orthobiologics industry global market size, regional shares, competitors with orthobiologics market share, detailed orthobiologics market segments, market trends, and opportunities, and any further data you may need to thrive in the orthobiologics industry. These orthobiologics market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The orthobiologics market size has grown strongly in recent years. It will grow from $6.65 billion in 2023 to $7.08 billion in 2024 at a compound annual growth rate (CAGR) of 6.4%. The growth in the historic period can be attributed to several factors, including the rise in the prevalence of orthopedic diseases and conditions, a shift towards minimally invasive procedures, an increase in the number of reconstructive surgeries, higher healthcare expenditure, increased awareness among patients and healthcare providers, and economic development in emerging markets.

The orthobiologics market size is expected to see strong growth in the next few years. It will grow to $9.12 billion in 2028 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to factors such as the aging population and sedentary lifestyles, ongoing development of advanced products, favorable reimbursement policies, regulatory approvals for new orthobiologic products, and expanded indications for existing orthobiologic products. Major trends in the forecast period include advancements in regenerative medicine, product innovations, technological advancements, strategic initiatives, and market expansion.

The orthobiologics market is poised for growth due to the increasing incidence of road accidents and sports injuries, which often result in musculoskeletal damage. These incidents are fueled by various factors such as distracted driving, speeding, unfavorable road conditions, overuse, inadequate equipment, and insufficient sports injury prevention measures. Orthobiologics play a crucial role in treating such injuries by facilitating faster and more effective healing of musculoskeletal tissues, reducing inflammation, and enhancing the body's natural repair processes. This is achieved through the application of substances such as bone grafts, growth factors, stem cells, and platelet-rich plasma. For example, in May 2022, the National Highway Traffic Safety Administration reported a 10.5% increase in motor vehicle crash fatalities in 2021, reaching approximately 42,915 deaths compared to 38,824 in 2020, indicating the growing demand for orthobiologics in addressing injuries from road accidents and sports.

Key players in the orthobiologics market are actively developing advanced solutions to improve bone healing and fusion in orthopedic procedures. Dry allograft mixtures, for instance, combine sturdy cortical fibers with mineralized cortical bone, offering structural support and promoting osteoinductive properties for new bone formation. Isto Biologics, a US-based biologics-focused company, introduced Fibrant Liberty allograft in May 2024, featuring robust cortical fibers integrated with mineralized cortical cancellous chips. This graft, upon hydration, becomes pliable and can be tailored for various surgical procedures. Its longer and stronger fibers improve handling and form a network that prevents graft migration while maintaining structural integrity.

In February 2023, Zimmer Biomet Holdings Inc., a US-based medical technology company, completed the acquisition of Embody Inc. for $155 million. This strategic move underscores Zimmer's commitment to investing in areas with significant growth potential and introducing innovations to benefit patients and surgeons. Embody, a US-based soft tissue healing company, specializes in developing and manufacturing collagen-based biologic products for soft tissue augmentation and repair. The acquisition includes Embody's comprehensive portfolio of collagen-based biointegrative solutions aimed at supporting healing in challenging orthopedic soft tissue injuries.

Major companies operating in the orthobiologics market are Johnson & Johnson, Medtronic plc, Zimmer Biomet, Arthrex Inc., Integra Lifesciences Corporation, NuVasive Inc., Globus Medical, Bioventus, MTF Biologics, ATEC Spine Inc., Exactech Inc., SeaSpine, RTI Surgical, AlloSource, XTANT MEDICAL, Spine Wave Inc., Bone Biologics Corp., Locate Bio Limited, Wright Medical Group N.V., BoneSupport AB, Graftys, Regenexx, Acumed LLC, Baxter International Inc., LifeNet Health

North America was the largest region in the orthobiologics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the orthobiologics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the orthobiologics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The orthobiologics market consists of sales of bone morphogenetic proteins, hyaluronic acid, stem cells, and platelet-rich plasma. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Orthobiologics Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on orthobiologics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for orthobiologics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The orthobiologics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Product Type: Viscosupplements; Bone Growth Factors; Demineralized Bone Matrix; Synthetic Bone Substitutes; Cellular Allograft; Other Products
2) By Application: Spinal Fusion; Maxillofacial And Dental; Soft Tissue Repair; Reconstructive And Fracture Surgery; Other Applications
3) By End User: Hospitals; Orthopedic Clinics; Ambulatory Surgery Centers; Other End Users
Companies Mentioned: Johnson & Johnson; Medtronic plc; Zimmer Biomet; Arthrex Inc.; Integra Lifesciences Corporation
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r18690

1. Executive Summary

2. Orthobiologics Market Characteristics

3. Orthobiologics Market Trends And Strategies

4. Orthobiologics Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Orthobiologics Market Size and Growth

5.1. Global Orthobiologics Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Orthobiologics Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Orthobiologics Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Orthobiologics Market Segmentation

6.1. Global Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Viscosupplements
Bone Growth Factors
Demineralized Bone Matrix
Synthetic Bone Substitutes
Cellular Allograft
Other Products
6.2. Global Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Spinal Fusion
Maxillofacial And Dental
Soft Tissue Repair
Reconstructive And Fracture Surgery
Other Applications
6.3. Global Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospitals
Orthopedic Clinics
Ambulatory Surgery Centers
Other End Users

7. Orthobiologics Market Regional And Country Analysis

7.1. Global Orthobiologics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Orthobiologics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Orthobiologics Market

8.1. Asia-Pacific Orthobiologics Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Orthobiologics Market

9.1. China Orthobiologics Market Overview
9.2. China Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Orthobiologics Market

10.1. India Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Orthobiologics Market

11.1. Japan Orthobiologics Market Overview
11.2. Japan Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Orthobiologics Market

12.1. Australia Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Orthobiologics Market

13.1. Indonesia Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Orthobiologics Market

14.1. South Korea Orthobiologics Market Overview
14.2. South Korea Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Orthobiologics Market

15.1. Western Europe Orthobiologics Market Overview
15.2. Western Europe Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Orthobiologics Market

16.1. UK Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Orthobiologics Market

17.1. Germany Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Orthobiologics Market

18.1. France Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Orthobiologics Market

19.1. Italy Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Orthobiologics Market

20.1. Spain Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Orthobiologics Market

21.1. Eastern Europe Orthobiologics Market Overview
21.2. Eastern Europe Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Orthobiologics Market

22.1. Russia Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Orthobiologics Market

23.1. North America Orthobiologics Market Overview
23.2. North America Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Orthobiologics Market

24.1. USA Orthobiologics Market Overview
24.2. USA Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Orthobiologics Market

25.1. Canada Orthobiologics Market Overview
25.2. Canada Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Orthobiologics Market

26.1. South America Orthobiologics Market Overview
26.2. South America Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Orthobiologics Market

27.1. Brazil Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Orthobiologics Market

28.1. Middle East Orthobiologics Market Overview
28.2. Middle East Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Orthobiologics Market

29.1. Africa Orthobiologics Market Overview
29.2. Africa Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Orthobiologics Market Competitive Landscape And Company Profiles

30.1. Orthobiologics Market Competitive Landscape
30.2. Orthobiologics Market Company Profiles
- 30.2.1. Johnson & Johnson
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Medtronic plc
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Zimmer Biomet
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Arthrex Inc.
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Integra Lifesciences Corporation
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Orthobiologics Market Other Major And Innovative Companies

31.1. NuVasive Inc.
31.2. Globus Medical
31.3. Bioventus
31.4. MTF Biologics
31.5. ATEC Spine Inc.
31.6. Exactech Inc.
31.7. SeaSpine
31.8. RTI Surgical
31.9. AlloSource
31.10. XTANT MEDICAL
31.11. Spine Wave Inc.
31.12. Bone Biologics Corp.
31.13. Locate Bio Limited
31.14. Wright Medical Group N.V.
31.15. BoneSupport AB

32. Global Orthobiologics Market Competitive Benchmarking

33. Global Orthobiologics Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Orthobiologics Market

35. Orthobiologics Market Future Outlook and Potential Analysis

35.1 Orthobiologics Market In 2028 - Countries Offering Most New Opportunities
35.2 Orthobiologics Market In 2028 - Segments Offering Most New Opportunities
35.3 Orthobiologics Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer